In AML, monocytes are prone to take up AML-derived extracellular vesicles (EVs) and subsequently differentiate, acquiring a CD14+HLA-DRlow phenotype and upregulating the expression of the immunoregulatory gene indoleamine-2,3-dioxygenase [178]. This evidence concerns the gene CD14 and acute myeloid leukemia.